Summary
EEG activity after activation of dopamine receptors of D-1 and/or D-2 type was studied by using telemetric recordings in rats. Apomorphine, a preferential D-2 agonist, produced a characteristic increase in the power of alpha-1 band (7.00–9.50 Hz) when given in doses mediating stereotypies (0.2 or 0.5 mg/kg s. c.). Low doses produced a general increase in the power of all of the bands except beta-2. In particular, delta activity was enhanced which seems to be in correspondence with the sedation observed after these doses (0.02 and 0.05 mg/kg). Haloperidol in a dose which is assumed to block both D-1 and D-2 receptors (0.1 mg/kg i. p.) completely antagonized the alpha-1 activation produced by apomorphine (0.5 mg/kg). A similar, although not complete inhibition of alpha-I activation was found after administration of a large dose of the selective D-1 antagonist SCH 23390 (0.2 mg/kg i. p.). The selective agonist at D-2 receptors quinpirole (1.0 mg/kg s. c.) produced a less pronounced activation of the power in the alpha-1 band than apomorphine.
In general, there was found to be a good correlation between the activation of the alpha-1 activity and stereotyped behaviour. The results suggest that for the full expression of alpha-1 activation, a pronounced activation of D-2 receptors and at least a minimal activation of D-1 receptors, for instance by the endogenous dopamine, is necessary.
Similar content being viewed by others
References
Ahrens H, Läuter J (1974) Mehrdimensionale Varianzanalyse; Academieverlag, Berlin
Andén N-E, Rubensson A, Fuxe K, Hoekfelt T (1967) Evidence for dopamine receptor stimulation by apomorphine. J Pharm Pharmacol 19:627–629
Bagetta G, De Sarro G, Priolo E, Nistico G (1988) Ventral tegmental area: site through which dopamine D2-receptor agonists evoke behavioural and electrocortical sleep in rats. Br J Pharmacol 95:860–866
Barone P, Davis TA, Braun AR, Chase TN (1986) Dopaminergic mechanisms and motor function: characterization of D-1 and D-2 dopamine receptor interactions. Eur J Pharmacol 123:109–114
Boyce S, Kelly E, Davis A, Fleminger S, Jenner P, Marsden CD (1985) SCH 23390 may alter dopamine-mediated motor behaviour via striatal D-1 receptors. Biochem Pharmacol 34:1665–1669
Carlsson A (1975) Receptor-mediated control of dopamine metabolism. In: Usdin E, Bunney WE Jr (eds) Pre- and postsynaptic receptors. Marcel Dekker Inc, New York, pp 49–63
Cools AR, van Rossum JM (1976) Excitation-mediating and inhibition-mediating dopamine receptors: a new concept towards better understanding of electrophysiological and pharmacological data. Psychopharmacologia 45:243–254
Dimpfel W, Spider M, Koch R, Schatton W (1987) Radioelectroencephalographic comparison of memantine with receptor-specific drugs acting on dopaminergic transmission in freely moving rats. Neuropsychobiology 18:212–218
Dimpfel W, Spüler M, Nickel B, Tibes U (1986) ‘Fingerprints’ of central stimulatory drug effects by means of quantitative radioelectroeneephalography in the rat (Tele-stereo-EEG). Neuropsychobiol 15:101–108
Ernst AM (1967) Mode of action of apomorphine and dexamphetamine in gnawing compulsion in rats. Psychopharmacology 10:316–323
Havemann U, Magnus B, Moeller HG, Kuschinsky K (1986) Individual and morphological differences in the behavioural response to apomorphine in rats. Psychopharmacology 90:40–48
Hyttel J (1983) SCH 23390, the first selective dopamine D-1 antagonist. Eur J Pharmacol 91:153–154
Iorio LC, Barnett A, Leitz FH, Houser VP, Korduba CA (1983) SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems. J Pharmacol Exp Ther 226:462–468
Johansson P, Levin E, Gunne L, Ellison G (1987) Opposite effects of a D1 and D2 agonist on oral movements in rats. Eur J Pharmacol 134:83–88
Kebabian JW, Calne DB (1979) Multiple receptors for dopamine. Nature 277:93–96
Laduron P (1980) Dopamine receptor: from an in vivo concept towards a molecular characterization. Trends in Pharmacol Sci 1:471–474
Ljungberg T, Ungerstedt U (1977) Different behavioural patterns induced by apomorphine: Evidence that the method of administration determines the behavioural response to the drug. Eur J Pharmacol 46:41–50
Mereu GP, Scarnati E, Paglietti E, Pellegrini Quarantotti B, Chessa P, Di Chiara G, Gessa GL (1979) Sleep induced by low doses of apomorphine in rats. Electroencephal Clin Neurophysiol 46:214–219
Molloy AG, Waddington JL (1985a) Sniffing, rearing and locomotor responses to the D-1 dopamine agonist R-SK&F 38393 and to apomorphine: differential interactions with the selective D-1 and D-2 antagonists SCH 23390 and metoclopramide. Eur J Pharmacol 108:305–308
Molloy AG, Waddington JL (1985b) The enantiomers of R-SK&F 83566, a new selective D-1 dopamine antagonist, stereospecifically block stereotyped behaviour induced by apomorphine and by the selective D-2 agonist RU 24213. Eur J Pharmacol 116:183–186
Ohno Y, Sasa M, Takaori S (1987) Coexistence of inhibitory dopamine D-1 and excitatory D-2 receptors on the same caudate nucleus neurons. Life Sci 40:1937–1945
Ongini E, Caporali MG (1987) Differential effects of dopamine D-1 and D-2 receptor agonists on EEG activity and behaviour in the rabbit. Neuropharmacology 26:355–360
Ongini E, Caporali MG, Longo VG (1987) Blockade of D-1 dopamine receptors by SCH 23390 prevents EEG and behavioural activation induced by L-DOPA. Neurosci Lett 82:206–210
Paxinos G, Watson C (1982) The rat brain in stereotactic coordinates. Academic Press, New York
Rosengarten H, Schweitzer JW, Friedhoff AJ (1986) Selective dopamine D2 receptor reduction enhances a D1 mediated oral dyskinesia in rats. Life Sci 39:29–35
Scheel-Krueger J (1986) The syndrome of sedation and yawning behaviour in the rat is dependent on postsynaptic D2-receptors. Psychopharmacology 89:S32
Shvaloff A, Tesolin B, Sebban C (1988) Effects of apomorphine in quantified electroencephalography in the frontal cortex: changes with doses and time. Neuropharmacology 27:1313–1317
Ståhle L, Ungerstedt U (1989) Yawning and suppression of exploration in amphetamine-treated rats, incompatibility with the autoreceptor hypothesis. Psychopharmacology 97:553–560
Stoof JC, Kebabian JW (1984) Two dopamine receptors: biochemistry, physiology and pharmacology. Life Sci 35:2281–2296
Thut PT, Rech RH (1972) Effects of L-DOPA on the EEG and brain amines of unrestrained rats. Exper Neurol 35:13–29
Vanderwolf CH, Szechtman H (1986) Electrophysical correlates of stereotyped sniffing in rats injected with apomorphine. Pharmacol Biochem Behav 26:299–304
Votava Z, Dyntarová H (1968) The effect of apomorphine on the EEG in rabbits and rats. In: Cerletti A, Bove FJ (eds) The present status of psychotropic drugs, pharmacological and clinical aspects; Proc. 6th. Int. Congr. Coll. Int. Neuro-Psychopharmacologicum, pp 294–296
Waddington JL (1986) Behavioural correlates of the action of selective D-1 dopamine receptor antagonists. Biochem Pharmacol 35:3661–3667
Walters JR, Bergstrom DA, Carlson JH, Chase TN, Braun AR (1987) D1 dopamine receptor activation required for postsynaptic expression of D2 agonist effects. Sciences 236:719–722
Yamamoto J (1988) Roles of cholinergic, dopaminergic, noradrenergic, serotinergic and GABAergic systems in changes of the EEG power spectra and behavioural states in rabbits. Jpn J Pharmacol 47:123–134
Young GA (1988) Relationship between amphetamine-induced effects on EEG power spectra and motor activity in rats. Pharmacol Biochem Behav 30:489–492
Author information
Authors and Affiliations
Additional information
Send offprint requests to K. Kuschinsky at the above address
Rights and permissions
About this article
Cite this article
Kropf, W., Kuschinsky, K. & Krieglstein, J. Apomorphine-induced alterations in cortical EEG activity of rats. Naunyn-Schmiedeberg's Arch Pharmacol 340, 718–725 (1989). https://doi.org/10.1007/BF00169680
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00169680